HERSX
Price
$15.16
Change
-$0.27 (-1.75%)
Updated
Jul 2 closing price
Net Assets
638.31M
VEMAX
Price
$48.88
Change
-$0.22 (-0.45%)
Updated
Jul 2 closing price
Net Assets
162.82B
Interact to see
Advertisement

HERSX vs VEMAX

HERSX vs VEMAX Comparison Chart in %
View a ticker or compare two or three
VS
HERSX vs. VEMAX commentary
Jul 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HERSX is a Hold and VEMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEMAX has more cash in the bank: 163B vs. HERSX (638M). VEMAX pays higher dividends than HERSX: VEMAX (2.28) vs HERSX (2.07). HERSX was incepted earlier than VEMAX: HERSX (15 years) vs VEMAX (20 years). HERSX (1.43) is less costly to investors than VEMAX (0.13). HERSX is a more actively managed with annual turnover of: 109.00 vs. VEMAX (6.00). HERSX has a lower initial minimum investment than VEMAX: HERSX (0) vs VEMAX (3000). HERSX annual gain was more profitable for investors over the last year : 34.08 vs. VEMAX (20.28). HERSX return over 5 years is better than : 48.18 vs. VEMAX (21.34).
HERSXVEMAXHERSX / VEMAX
Total Expense Ratio1.430.131,100%
Annual Report Gross Expense Ratio1.430.131,100%
Fund Existence15 years20 years-
Gain YTD21.8659.644227%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets638M163B0%
Annual Yield % from dividends2.072.2891%
Returns for 1 year34.0820.28168%
Returns for 3 years84.1252.70160%
Returns for 5 years48.1821.34226%
Returns for 10 years156.7097.33161%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LBISX23.670.31
+1.33%
BrandywineGLOBAL Div US Large Value IS
EPLDX25.980.18
+0.70%
NYLI Epoch U.S. Equity Yield Class R6
ASEFX18.67-0.11
-0.59%
Nuveen Small Cap Select R6
MEGRX158.73-1.16
-0.73%
MFS Growth R2
FRSGX40.11-0.56
-1.38%
Franklin Small-Mid Cap Growth A